Novus Diagnostics are developing a revolutionary sample-to-answer sepsis diagnostic device.
Novus Diagnostics has raised $4.7M in total funding. The most recent round was Seed. The last funding was announced in January 2025.
Novus Diagnostics's investors include Enterprise Ireland, European Innovation Council, Trinity Biotech, Business Venture Partners, EIT Health.
Novus Diagnostics is headquartered in Dublin, Ireland.
Novus Diagnostics are developing a revolutionary sample-to-answer sepsis diagnostic device.
Novus Diagnostics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Novus Diagnostics — Funding & Investors." VCBacked, January 15, 2025, https://www.vcbacked.co/company/novus-diagnostics. Accessed July 19, 2026.
VCBacked. (2025). Novus Diagnostics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/novus-diagnostics
{{cite web |title=Novus Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/novus-diagnostics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated